NABsys
About Our Technology
NABsys scientists, in close collaboration with scientists at Brown University, are developing NABsys’s proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. HANS combines nanopore sequencing with sequencing-by-hybridization (SBH) to create what NABsys believes will be the lowest cost, fastest whole-genome sequencing technology available.
To learn how HANS works, please watch the tutorial on our technology page.
Why we do what we do
Most diseases have strong genetic components. This includes diseases such as heart disease and cancer, the diseases that claim the most lives in the West. However, there is currently limited understanding of the role genetics plays in these diseases and very limited use of this knowledge in clinical care. NABsys’s mission is to change this.
NABsys aims to usher in the era of individualized and preventive medicine through whole-genome sequencing that is truly inexpensive and accurate enough to be used to guide clinical care.
How we do what we do
NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.